Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE

American Journal of Physiology - Endocrinology and Metabolism

Volumn 280, Issue 5 43-5, 2001, Pages

  Wautier, Marie Paule ^a,b   Chappey, Olivier ^a   Corda, Stefano ^a   Stern, David M ^c   Schmidt, Ann Marie ^c   Wautier, Jean Luc ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b INSERM   (France)

^c Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

Cellular activation; Diabetes; Glycation; Receptors; Renal failure

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; DIPHENYLIODONIUM SALT; HYDROGEN PEROXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THROMBOPLASTIN; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ARTICLE; ENZYME ACTIVATION; ERYTHROCYTE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0034996659     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.2001.280.5.e685     Document Type: Article

References (60)

1. ε-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. J Clin Invest 104: 103-113, 1999.
2. Andersson KB, Sletten K, Berntzen HB, Dale I, Brandtzaeg P, Jellum E, and Fagerhol MK. The leucocyte L1 protein: identity with the cystic fibrosis antigen and the calcium-binding MRP-8 and MRP-14 macrophage components. Scand J Immunol 28: 241-245, 1998.
3. Brownlee M. Advanced glycosylation in diabetes and aging. Ann Rev Med 46: 223-234, 1995.
4. Degenhardt TP, Thorpe SR, and Baynes JW. Chemical modification of proteins by methylglyoxal. Cell Mol Biol 44: 1139-1145, 1998.
5. Duranteau J, Chandel NS, Kulisz A, Shao Z, and Shumacker PT. Intracellular signalling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 273: 11619-11624, 1998.
6. Dyer D, Dunn J, Thorpe S, Bailie K, Lyons T, McCance D, and Baynes J. Accumulation of Maillard products in skin collagen in diabetes and aging. J Clin Invest 91: 2463-2469, 1993.
7. Faggioni R, Gatti S, Demitri MT, Delgado R, Echtenacher B, Gnocchi P, Heremans H, and Ghezzi P. Role of xanthine oxidase and reactive oxygen intermediates in LPS and TNF-induced pulmonary edema. J Lab Clin Med 123: 394-399, 1994.
8. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, and Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87: 26-32, 2000.
9. Habeeb AF. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem 14: 328-336, 1966.
10. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, and Schmidt AM. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97: 889-901, 1999.
11. Hoogwerf BJ and Young JB. The HOPE study: ramipril lowered cardiovascular risk, but vitamin E did not. Clevel Clin J Med 67: 287-293, 2000.
12. Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen J, Nagashima M, Nitecki D, Morser J, Stern D, and Schmidt AM. The receptor for advanced glycation endproducts (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and coexpression of RAGE and amphoterin in the developing nervous system. J Biol Chem 270: 25752-25761, 1995.
13. Huttunen HJ, Fages C, and Rauvala H. RAGE-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signalling pathways. J Biol Chem 274: 19919-19924, 1999.
14. Ikeda K, Higashi T, Sano H, Jinnouchi Y, Yoshida M, Araki T, Ueda S, and Horiuchi S. Carboxymethyllysine protein adduct is a major immunological epitope in proteins modified with AGEs of the Maillard reaction. Biochemistry 35: 8075-8083, 1996.
15. Kirk EA, Dinauer MC, Rosen H, Chait A, Heinecke JW, and LeBoeuf RC. Impaired superoxide production due to deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler Thromb Vasc Biol 20: 1529-1535, 2000.
16. ε(carboxymethyl)lysine modifications of proteins are ligands for RAGE that activate cell signalling pathways and modulate gene expression. J Biol Chem 274: 31740-31749, 1999.
17. Kubo H, Morgenstern D, Quinlan WM, Ward PA, Dinauer MC, and Doerschuk CM. Preservation of complement-induced lung injury in mice with deficiency of NADPH oxidase. J Clin Invest 97: 2680-2684, 1996.
18. Lalla E, Lamster IB, Feit M, Huang L, Spessot A, Qu W, Kislinger T, Lu Y, Stern DM, and Schmidt AM. Blockade of RAGE suppresses periodontitis-associated alveolar bone loss in diabetic mice. J Clin Invest 105: 1117-1124, 2000.
19. Lander HM, Hajjar DP, Hempstead BL, Mirza UA, Chait BT, Campbell S, and Quilliam LA. A molecular redox switch on p21(ras): structural basis for the nitric oxide-p21(ras) interaction. J Biol Chem 272: 4323-4326, 1997.
20. Lander HM, Milbank AJ, Tauras JM, Hajjar DP, Hempstead BL, Schwartz GD, Kraemer RT, Mirza UA, Chait BT, Burk SC, and Quilliam LA. Redox regulation of cell signalling. Nature 381: 380-381, 1996.
21. Lander HM, Tauras JM, Ogiste JS, Moss RA, and Schmidt AM. Activation of the receptor for advanced glycation endproducts triggers a MAP kinase pathway regulated by oxidant stress. J Biol Chem 272: 17810-17814, 1997.
22. Lugering N, Stoll R, Schmid KW, Kucharzik T, Stein H, Burgmeister G, Sorg C, and Domschke W. The myeloic related protein MRP8/14 (27E10 antigen) - usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function. Eur J Clin Invest 25: 659-664, 1995.
23. Madson P. Molecular cloning, occurrence and expression of a novel partially secreted protein "psoriasin" that is highly upregulated in psoriatic skin. J Invest Dermatol 97: 701-712, 1991.
24. Matheny HE, Deem TL, and Cook-Mills JM. Lymphocyte migration through monolayers of endothelial cell lines involves VCAM-1 signaling via endothelial cell NADPH oxidase. J Immunol 164: 6550-6559, 2000.
25. McWilliam AS, Tree P, and Gordon S. Interleukin-4 regulates induction of sialoadhesin, the macrophage sialic acid-specific receptor. Proc Natl Acad Sci USA 89: 10522-10526, 1992.
26. Meier B, Cross AR, Hancock JT, Kaup FJ, and Jones OT. Identification of a superoxide-generating NADPH oxidase system in human fibroblasts. Biochem J 275: 241-245, 1991.
27. 2-microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway: implications for the pathogenesis of dialysis-related amyloidosis. J Clin Invest 98: 1088-1094, 1996.
28. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, Elliston K, Stern DM, and Shaw A. Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267: 14998-15004, 1992.
29. O'Brien DP. The molecular biology and biochemistry of tissue factor. Baillieres Clin Haematol 2: 801-820, 1989.
30. Odink K, Cerletti N, Brueggen J, Clerc RG, Tarcasy L, Zwadlo G, Gerhards G, Schlegel R, and Sorg C. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 330: 80-82, 1987.
31. O'Donnell BV, Tew DG, Jones TG, and England PJ. Studies on the inhibitory mechanism of iodonium compounds with special reference to the neutrophil NADPH oxidase. Biochem J 290: 41-49, 1993.
32. Pahler A, Volkel W, and Dekant W. Quantitation of N-epsilon-(dichloroacetyl)-L-lysine in proteins after perchloroethene exposure by gas chromatography-mass spectrometry using chemical ionization and negative ion detection following immunoaffinity chromatography. J Chromatogr 847: 25-34, 1999.
33. Palinski W, Koschinsky T, Butler S, Miller E, Vlassara H, Cerami A, and Witztum J. Immunological presence of AGEs in atherosclerotic lesions of euglycemic rabbits. Atheroscler Thromb Vasc Biol 15: 571-582, 1995.
34. Pick E and Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods 38: 161-170, 1980.
35. Pollock JD, Williams DA, Gifford MAC, Li LL, Du X, Fisherman J, Orkin SH, Doerschuk DM, and Dinauer MC. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nature Genet 9: 202-209, 1995.
36. Pouplard C, Recerdiau-Moalic P, Piquemal R, Watier H, Lebranchu Y, Bardos P, and Gruel Y. A simplified and low-cost one-stage chromogenic assay for tissue factor dependent procoagulant activity of endothelial cells. Thromb Res 80: 527-534, 1995.
37. Reddy S, Bichler J, Wells-Knecht K, Thorpe S, and Baynes J. Carboxymethyllysine is a dominant AGE antigen in tissue proteins. Biochemistry 34: 10872-10878, 1995.
38. Regnstrom J, Walldius G, Nilsson S, Elinder LS, Johansson J, Molgaard J, Holme I, Olsson AG, and Nilsson J. The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis. Atherosclerosis 125: 217-229, 1996.
39. Renard C, Chappey O, Wautier MP, Nagashima M, Lundh E, Morser J, Zhao L, Schmidt AM, Scherrmann JM, and Wautier JL. Recombinant soluble advanced glycation endproduct receptor pharmacokinetics in normal and diabetic rats. Mol Pharmacol 52: 54-62, 1997.
40. Rothe G and Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′-7′-dichlorofluorescin. J Leucocyte Biol 47: 440-448, 1990.
41. Royall JA and Ischiropoulos H. Evaluation of 2′-7′-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular hydrogen peroxide in cultured endothelial cells. Arch Biochem Biophys 302: 348-355, 1993.
42. Satriano JA, Shuldiner M, Hora K, Xing Y, Shan Z, and Schlondorff D. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J Clin Invest 92: 1564-1571, 1993.
43. Schafer BW and Heinzmann CW. The S100 family of EF-hand calcium-binding proteins: functions and pathology. Trends Biochem Sci 21: 134-140, 1996.
44. Schmidt AM, Hori O, Chen J, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, and Stern D. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1): a potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96: 1395-1403, 1995.
45. Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, Esposito C, Hegarty H, Hurley W, Clauss M, Wang F, Pan YC, Tsang TC, and Stern D. Isolation and characterization of binding proteins for advanced glycosylation endproducts from lung tissue which are present on the endothelial cell surface. J Biol Chem 267: 14987-14997, 1992.
46. Schmidt AM, Yan SD, Wautier JL, and Stern D. Activation of receptor for advanced glycation endproducts: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 84: 489-497, 1999.
47. Serron SC, Dwivedi N, and Backes WL. Ethylbenzene induces microsomal oxygen free radical generation: antibody-directed characterization of the responsible cytochrome P450 enzymes. Toxicol Appl Pharmacol 164: 305-311, 2000.
48. Smith MA, Taneda S, Richey P, Miyata S, Yan SD, Stern D, Sayre LM, Monnier VM, and Perry G. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91: 5710-5714, 1994.
49. Suzuki K, Yamamoto T, Sato A, Murayama T, Amitani R, Yamomoto K, and Kuze F. LPS primes human alveolar macrophages for enhanced release of superoxide anion and leukotriene B4: self-limitations of the priming response with protein synthesis. Am J Respir Cell Mol Biol 8: 500-508, 1993.
50. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C, Hofmann MA, Kislingler T, Ingram M, Lu A, Tanaka H, Hori O, Ogawa S, Stern DM, and Schmidt AM. Blockade of amphoterin/RAGE signalling suppresses tumor growth and metastases. Nature 405: 354-360, 2000.
51. Wautier JL, Wautier MP, Schmidt AM, Anderson GM, Zoukourian C, Capron L, Chappey O, Yan SD, Brett J, Guillausseau PJ, and Stern D. Advanced glycation endproducts (AGEs) on the surface of diabetic red cells bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci USA 91: 7742-7746, 1994.
52. Wautier JL, Zoukourian C, Chappey O, Wautier MP, Guillausseau PJ, Cao R, Hori O, Stern D, and Schmidt AM. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation endproducts blocks hyperpermeability. J Clin Invest 97: 238-243, 1996.
53. Wautier MP, Boval B, Chappey O, Enjolras O, Wernert N, Merland JJ, and Wautier JL. Cultured endothelial cells from human arteriovenous malformations have defective growth regulation. Blood 94: 2020-2028, 1999.
54. Wullner U, Seyfried J, Groscurth P, Beinroth S, Winter S, Gleichmann M, Heneka M, Loschmann P, Schulz JB, Weller M, and Klockgether T. Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function. Brain Res 826: 53-62, 1999.
55. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Nagashima M, Morser J, Migheli A, Nawroth P, Godman G, Stern D, and Schmidt AM. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691, 1996.
56. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, and Stern D. Enhanced cellular oxidant stress by the interaction of AGEs with their receptors/binding proteins. J Biol Chem 269: 9889-9897, 1994.
57. Yan SD, Zhu H, Fu J, Yan SF, Roher A, Tourtellotte W, Rajavashisth T, Chen X, Stern D, and Schmidt AM. Amyloid-beta peptide-RAGE interaction elicits neuronal expression of M-CSF: a proinflammatory pathway in Alzheimer's disease. Proc Natl Acad Sci USA 94: 5296-5301, 1997.
58. Yan SD, Zhu H, Zhu A, Golabek A, Du H, Roher A, Yu J, Soto C, Schmidt AM, Stern D, and Kindy M. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nature Med 6: 643-651, 2000.
59. Yusuf S, Degenais G, Pogue J, Bosch J, and Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342: 154-160, 2000.
60. Zimmer DB, Cornwall EH, Landar A, and Song W. The S100 protein family: history, function, and expression. Brain Res Bull 37: 417-429, 1995.